by Gene Tarne/LifeNews.com
It would seem that the California Institute for Regenerative Medicine (CIRM) is not alone as it increasingly moves away from human embryonic stem cell research (hESCR) and towards adult and other non-embryonic avenues of stem cell research.
As a recent Lozier Institute study reported, over the years since it was founded to provide financial support for hESCR, CIRM has instead been awarding more and more grants to adult stem cell research. CIRM’s current strategic plan has as its goal moving projects as quickly as possible to the clinical trial phase, and its pattern of awarding more and more grants to adult stem cell research would indicate that hESCR is falling far short of achieving this goal.
Enter the University of Massachusetts Stem Cell Bank. Or, rather, exit the University ofMassachusetts Stem Cell Bank.
According to news reports, the stem cell bank will run out of money at the end of the year and, when it does, state officials and officials at the University of Massachusetts have agreed to just let it close.
This was not how things were supposed to turn out. As was the case with CIRM, the University of Massachusetts Stem Cell Bank was conceived as push-back against President Bush’s policy of limited federal funding for hESCR.